EP, Devaney JM. CCL2 and CCR2 variants are associated with skeletal muscle strength and change in strength with resistance training. J Appl Physiol 109: 1779-1785. First published October 14, 2010 doi:10.1152/japplphysiol.00633.2010.-Baseline muscle size and muscle adaptation to exercise are traits with high variability across individuals. Recent research has implicated several chemokines and their receptors in the pathogenesis of many conditions that are influenced by inflammatory processes, including muscle damage and repair. One specific chemokine, chemokine (C-C motif) ligand 2 (CCL2), is expressed by macrophages and muscle satellite cells, increases expression dramatically following muscle damage, and increases expression further with repeated bouts of exercise, suggesting that CCL2 plays a key role in muscle adaptation. The present study hypothesizes that genetic variations in CCL2 and its receptor (CCR2) may help explain muscle trait variability. College-aged subjects [n ϭ 874, Functional Single-Nucleotide Polymorphisms Associated With Muscle Size and Strength (FAMUSS) cohort] underwent a 12-wk supervised strength-training program for the upper arm muscles. Muscle size (via MR imaging) and elbow flexion strength (1 repetition maximum and isometric) measurements were taken before and after training. The study participants were then genotyped for 11 genetic variants in CCL2 and five variants in CCR2. Variants in the CCL2 and CCR2 genes show strong associations with several pretraining muscle strength traits, indicating that inflammatory genes in skeletal muscle contribute to the polygenic system that determines muscle phenotypes. These associations extend across both sexes, and several of these genetic variants have been shown to influence gene regulation.
thesis and protein degradation (3, 4, 17, 25) . While it seems clear that these pathways impact muscle size and strength, evidence suggests that they are not the only contributors.
Exercise involving lengthening (eccentric) contractions can cause increased muscle hypertrophy and skeletal muscle damage. Therefore, genes involved in the body's response to muscle injury/damage have the potential to influence muscle size and strength. One class of genes involved in this response is the chemokines. Chemokines (chemotactic cytokines) are small proteins that direct circulating leukocytes to areas of inflammation or injury (5) . In addition to their role in inflammation, chemokines and chemokine receptors contribute to the pathogenesis of many diseases (14, 21, 23) . One of the most thoroughly characterized members of this family is monocyte chemoattractant protein 1, also known as chemokine (C-C motif) ligand 2 (CCL2). CCL2 and one of its major receptors, monocyte chemoattractant protein 1 receptor (CCR2), are encoded by the genes CCL2 and CCR2, respectively. Initial interest in CCL2 as a potential modifier of muscle arose from studies that showed significant upregulation of CCL2 and CCR2 after muscle injury and during muscle regeneration (16, 30, 33, 34) .
Considering the potential role of CCL2 and CCR2 in the inflammatory response and subsequent repair of injured muscle, we sought to determine whether variants in their respective genes might influence skeletal muscle phenotypes. In addition, we have shown that variants in CCL2 and CCR2 are associated with measures of muscle damage and preexercise muscle strength in the legs of human volunteers as part of a muscle damage study (19) . We examined 11 CCL2 single-nucleotide polymorphisms (SNPs) and five CCR2 SNPs for associations with muscle size and strength and changes in size and strength by using a cohort from the FAMUSS (Functional SingleNucleotide Polymorphisms Associated With Muscle Size and Strength) study. The FAMUSS study was designed to examine the influence of genetic variation on skeletal muscle size and strength before and after resistance exercise (for a review of the FAMUSS study see Ref. 31 ). We discovered that several SNPs in CCL2 and CCR2 are associated with measures of muscle strength before resistance training and two variants are associated with percent change in muscle strength following resistance training.
MATERIALS AND METHODS
Subjects. The population used for this study was derived from a large multicenter study (FAMUSS) designed to identify genetic variants that influence muscle size and strength and individual variability in the response to resistance training. The study has been described in detail elsewhere (31) . Briefly, 874 healthy Caucasian subjects between the ages of 18 and 40 yr (360 men, 514 women; average age ϭ 23 yr) volunteered for the study (Table 1) . None of the participants had performed strength training or worked in a job requiring repetitive use of the arms for 12 mo prior to starting the study. Furthermore, study participants were not taking medications known to affect skeletal muscle and were not taking dietary supplements reported to increase muscle size or strength. Written informed consent was obtained from each subject. The study was approved by the Children's National Medical Center Institutional Review Board (protocol 2449).
Maximal voluntary isometric contraction and dynamic elbow flexion strength testing. Strength testing of the elbow flexor muscles was performed before and after 12 wk of progressive strength training. Maximal voluntary isometric contraction (MVC) strength of each arm was determined by using a specially designed preacher bench coupled with a strain gauge (model 32628CTL, Lafayette Instrument, Lafayette, IN). MVC force was defined as the average of three 3-s trials, with 1 min between trials. Dynamic elbow flexor strength of each arm was assessed via one-repetition maximum (1 RM) test, determining the maximum amount of weight with which a subject could perform one repetition of the standard preacher bench curl exercise.
MR imaging measurement. Entry MR imaging (MRI) was done 24 -48 h before baseline strength testing. Posttraining MRI was performed 48 -96 h after the last training session. Fifteen 16-mm contiguous axial slices were collected from each arm independently. Because MRIs were collected before and after training, it was important that each subject's positioning within the MR magnet be reliably reproduced to maintain consistency between pre-and posttraining measurements. To accomplish this, the maximum circumference of the upper arm (i.e., the belly of the muscle) was measured with a vinyl, nonstretchable tape measure while the arm was abducted 90°at the shoulder and flexed 90°at the elbow and the biceps was maximally contracted. A radiographic bead (Beekley Spots, Beekley, Bristol, CT) was used to mark the location of the maximum circumference, referred to as the point of measure, on the subject's skin (9) . The top of the bead in a sagittal scout view was used to locate the eighth slice going from the top of the arm toward the elbow. Scans for both arms were taken by fast spoiled gradient recalled and fast spin echo, with an echo time of 1.9 s and a repetition time of 200 ms. All eight study centers submitted the MRI data to the Research Center for Genetic Medicine at Children's National Medical Center via e-mail or DAT disk, and all scans were integrated into the study structured query language (SQL) database.
Volumetric (3-dimensional) analysis of the MRIs was performed using Rapidia (INFINITT, Seoul, Korea), a personal computer-based software that enables semiautomatic quantification of muscle and fat from MRIs. Volume measures were taken by using an anatomic landmark (metaphyseal-diaphyseal junction of the humerus) as a starting point and then measuring the six 1-cm slices proximal to it. Measurement values were automatically written and saved, together with anthropomorphic and genotyping data, in an SQL database. MRIs of sufficient quality were quantified from 546 of the individuals enrolled; subjects whose MRIs did not pass quality control requirements were excluded (Table 1) .
Muscle quality and torque calculations. Torque was calculated for each arm at each time point using the following equation:
Muscle quality was then calculated as torque (N·m) Ϭ muscle volume (mm 3 ). Resistance-training program. All subjects underwent 12 wk of progressive resistance training using their nondominant arm only. The training exercises targeted the muscles in the upper arm and included three exercises for the biceps and two for the triceps. The subjects trained twice a week for 12 wk, with each training session supervised and lasting ϳ45-60 min. Pretraining 1-RM measurements were used to estimate the weights that could be lifted for 12, 8, and 6 repetitions using standard formulas (35) . The exercise progression used the following weekly training protocol: 3 sets with 12 repetitions of the 12-RM weight (65-75% of 1 RM) in weeks 1-4, 3 sets with eight repetitions of the 8-RM weight (76 -82% of 1 RM) in weeks 5-9, and 3 sets with 6 repetitions of the 6-RM weight (83-90% of 1 RM) in weeks 10 -12. The subjects were given a 2-min rest period between each set for a particular exercise and before moving on to the next exercise. This protocol was designed to increase 1) muscle size, using high repetitions at low intensity early in training, and 2) strength, using low repetitions at high intensity as training progressed (29) .
Genotyping. Venous blood samples were collected from fasting subjects at the start of the study and sent to the coordinating site (Children's National Medical Center) with all subject identification information removed. The Gentra Puregene Blood DNA purification kit (Qiagen, Valencia, CA) was used to isolate DNA from each blood sample. Genotyping was performed using the Taqman allele discrimination assay (Applied Biosystems) using standard thermal cycling conditions, with genotypes called by the Applied Biosystems 7900HT Real-Time PCR system. For most of the SNPs, the Applied Biosystems assay ID is shown in Supplemental Table S1 (see Supplemental Material for this article, available online at the Journal website). If the SNP was not commercially available on the Applied Biosystems website, than a custom primer set was designed (see Supplemental  Table S3 ). Variants were chosen on the basis of the literature evidence for function (22) or an assigned function by the program PupaSuite 2 (7) (see Supplemental Table S3 ).
Statistical analysis. All analyses were stratified by sex because of large sex differences in baseline values and the response to training. 2 Tests determined Hardy-Weinberg equilibrium for each SNP to compare the observed genotype frequencies with those expected under Hardy-Weinberg equilibrium. Bivariate correlation analyses of each quantitative measurement revealed significant correlations with age and body weight. Consequently, associations between SNPs and each phenotype were tested using analysis of covariance, with age and baseline body weight as covariates. All analyses of covariance used a dominant genetic model comparing homozygous common allele individuals with combined heterozygotes and homozygous rare allele individuals. The percent variation attributable to genotype was calculated by comparing the full model (genotype and covariates) with the constrained model (covariates only) and tested using a likelihood-ratio test.
Linkage disequilibrium calculations. Linkage disequilibrium was determined between all pairs of SNPs using the correlation coefficient r 2 (see Supplemental Table S5 ).
RESULTS
Strength and muscle size response to training. Before the study was completed, we published an article describing variability in muscle size and strength changes in a smaller cohort of men and women that were part of the FAMUSS data set (20) . However, this data set expands to all individuals who participated in the FAMUSS study. Pre-and posttraining values for the muscle strength and size phenotypes are located in Table 2 . On average, men and women improved their strength with resistance training as measured by 1 RM, with women gaining 63% (range 0 to ϩ9 kg) and men gaining 40% (range 0 to ϩ12 kg). However, two men (0.6%) and 11 women (2.3%) did not gain any strength (maintained the same 1-RM value as pretraining) following the 12-wk resistance-training program (see Supplemental Table S3 ).
Women gained 24% MVC strength (range Ϫ21 to ϩ43 kg) with training and men gained 18% (range Ϫ13 to ϩ53 kg) following resistance training on the one arm. Interestingly, more men (n ϭ 35, 11.1%) and women (n ϭ 56, 11.8%) lost MVC strength following resistance training than did not gain strength in 1 RM (see Supplemental Table S3) .
With resistance training, men gained 13.4% skeletal muscle volume of the biceps (range of muscle volume of the biceps Ϫ31,693 to ϩ212,500 mm 3 ) and women gained 9.5% biceps volume (range of muscle volume of the biceps Ϫ82,823 to ϩ146,860 mm 3 ). Thirty-seven women and six men lost skeletal muscle volume with training. Of the 37 women who lost muscle volume, 36 gained 1-RM strength and 1 did not change 1-RM strength. All six men who lost muscle volume with training showed gain in 1-RM strength and MVC strength (see Supplemental Table S3 ).
Genotype associations. In our population of individuals who are of European descent (Caucasians), we genotyped 11 genetic variants in the chemokine gene CCL2 (rs17652343, rs1860189, rs3917878, rs2857654, rs1024611, rs1024610, rs3760396, rs2857656, rs2857657, rs4586, and rs13900) and five variants in the chemokine receptor gene CCR2 (rs17141010, rs768539, rs3918358, rs1799864, and rs1799865). The genotype distribu- tions and allele frequencies, along with allele frequencies for the common allele in individuals of European descent, are shown in Supplemental Table S1 . All the SNPs tested were in HardyWeinberg equilibrium. We also calculated linkage disequilibrium between all pairs of SNPs using the correlation coefficient r 2 (see Supplemental  Table S5 ) 94) . None of the SNPs were in perfect linkage disequilibrium, and we report results for all associated SNPs because of their potential functional consequences (see Supplemental Table S4 ).
Five variants in the CCL2 gene were found to be associated with strength or muscle volume phenotypes (Table 3) . The rs1024611 nonancestral (G) allele variant was associated with pretraining muscle quality in women; in men, the G allele was associated with pretraining 1-RM strength, MVC strength, 1-RM torque, MVC torque, and 1-RM muscle quality. This variant was not associated with changes in muscle size and strength following the 12-wk training period.
In men with a copy of the ancestral (T) allele for the rs1024610 SNP, percent change in MVC strength was higher following the training program. This was the only variant in the CCL2 gene associated with change in strength or muscle size following the training period.
In women with a copy of the nonancestral (G) allele for the rs2857656 variant, pretraining 1-RM and MVC muscle quality were higher. In men with the same allele, pretraining values of 1 RM and 1-RM torque were higher. Only men showed an association with the rs4586 SNP, with the ancestral allele (C) associated with higher values of pretraining 1-RM and MVC strength and with pretraining MVC and 1-RM torque.
The nonancestral (T) allele for the rs13900 SNP was associated with higher pretraining values of 1-RM muscle quality for women and higher values of pretraining MVC strength, MVC muscle quality, 1-RM muscle quality, and 1-RM strength for men.
For the CCR2 gene, three variants were associated with preor posttraining muscle and strength phenotypes. In men and women with two copies of the C allele for the rs768539 variant, values for pretraining muscle quality and 1-RM strength, respectively, were higher. In individuals with two copies of the A allele for the rs3918358 SNP or two copies of the T allele for the rs1799865 SNP, response of 1-RM strength to the 12-wk training program was greater.
DISCUSSION
In this study, we examined 11 CCL2 SNPs and 5 CCR2 SNPs for associations with skeletal muscle volume, strength, and change in muscle volume and strength with resistance training. We found four variants in the CCL2 gene (rs1024611, rs2857656, rs4586, and rs13900) associated with pretraining strength and one variant (rs1024610) associated with an increase in strength in response to a 12-wk resistance-training program. In addition, we found one variant (rs768539) in the CCR2 gene associated with pretraining strength and two CCR2 gene variants (rs3918358 and rs1799865) associated with an increase in 1-RM strength following completion of a 12-wk resistance-training program. The associated SNPs explained 0.7-2.5% of the phenotype. Although this is a low percentage of phenotype explained by the individual variants, the values are higher than those reported in some of the large genomewide association studies for phenotypes such as body mass index (BMI), where a common variant in the FTO gene explained ϳ1% of the BMI in 39,000 individuals (15) . There was no association with pretraining skeletal muscle size or change in muscle size and the examined genetic variants.
There is substantial evidence that CCL2 plays a role in muscle phenotypes by mediating the inflammatory response to muscle damage or injury. Previous studies have indicated a clear link between the inflammatory response and the subsequent repair process in skeletal muscle (16, 30) . An increase in the mechanical loading of skeletal muscle results in the accumulation of neutrophils and macrophages in muscle (11) , and macrophages have been shown to be essential for hypertrophy in response to this stimulus (11, 32) . In fact, muscle lacking macrophages shows impaired recovery from injury (34) . CCL2 plays a role in the recruitment of macrophages to sites of injury (6) and, therefore, may be critical to initiating the recovery process. Additionally, resistance training results in increased expression of CCL2 by satellite cells and macrophages (18), both of which are necessary for recovery after muscle injury.
Recent studies also suggest a role for CCR2 protein in influencing muscle phenotypes. In mice, CCR2 was upregulated in response to muscle injury (3). When CCR2 is knocked out, mice show impaired muscle recovery following injury, marked by extended inflammation, fibrosis, fat infiltration, and delayed recovery of strength (33) .
Most of the phenotypes that were associated with CCL2 and CCR2 SNPs in this study are pretraining values of muscle strength. We recently published a study showing that variants in CCL2 and CCR2 are associated with exercise-induced damage following maximal eccentric exercise (19) . Although the associations between CCL2/CCR2 variants and recovery from muscle injury (19, 34 ) support a role for these genes in skeletal muscle, CCL2 and CCR2 have not historically been characterized as regulators of muscle hypertrophy or strength.
Our data uncover associations with SNPs previously found to have a role in regulating basal unstimulated CCL2 levels (22) . The rare allele (G) for rs1024611, which we found to be associated with pretraining strength in men and women, is also associated with higher serum levels of CCL2 (22) . In addition, the rare allele (T) for rs1024610, which in our study is associated with an increase in MVC strength in men following resistance training, has been shown to be associated with higher serum levels of CCL2 (22) . Two other CCL2 variants (rs2857656 and rs13900; high linkage disequilibrium) that are associated with strength in men and women in our study are predicted to be involved in transcriptional regulation of CCL2 by PupaSuite 2 (7) (see Supplemental Table S4 ). The common allele (C) for variant rs4586 in CCL2 is associated with pretraining strength in men and is predicted to be involved in splicing regulation by PupaSuite 2 (7) . All the associations that we have found for CCL2 SNPs are in distal regulatory regions or predicted regulatory regions. Further work will help uncover the function of these variants in skeletal muscle.
The rs768539 variant in CCR2 is associated with pretraining values of muscle quality in men and pretraining strength in women. This SNP is predicted by PupaSuite 2 to interrupt a SOX9 transcription factor-binding site (7) . SOX9 is modulated by androgens, which in turn are modulators of skeletal muscle adaptation and regeneration (10) . The addition of dihydrotestosterone represses the expression of SOX9 and increases the expression of myostatin (10) . Myostatin, a member of the transforming growth factor superfamily, is the single most powerful negative regulator of developmental myogenesis, as demonstrated by marked muscle hypertrophy in homozygous mutant mice and cattle and a single known human case (1) . Therefore, the rs768539 variant may influence muscle by eliminating a SOX9 binding site, thus affecting SOX9 levels and androgen regulation in muscle.
Two of the CCR2 variants (rs3918358 and rs1799865; high linkage disequilibrium) are associated with the response to resistance training (1 RM) in men. Both of these SNPs are predicted to have an effect on transcriptional regulation using PupaSuite 2 (7). However, this needs to be verified with in vitro studies.
Our study discovered that most genetic associations for the CCL2 and CCR2 variants that were part of our study were limited to measures of preexercise strength (MVC or 1 RM) and not associated with changes in muscle size as measured by MRI. In addition, some of the variants were associated with only one measure of pretraining strength (MVC or 1 RM) or a change with training of only one measure of strength. The measure of 1 RM is not just fundamental strength of the muscle group that is undergoing measurement but requires the actions of synergistic and stabilizing muscles (24) , and some even question its suitability for detailed physiological assessment (13) . The genetics that govern 1-RM and MVC strength need to be explored.
The lack of association between skeletal muscle size and variation in the CCL2/CCR2 gene is unexpected. It has been shown that CCL2 gene expression is increased with skeletal muscle regeneration after injury or repeated bouts of exercise (8, 18, 27, 30) ; however, not much work has been done on CCL2 levels in preexercise or preinjury skeletal muscle states. This is also true for the receptor, CCR2, which has been shown to be involved in skeletal muscle regeneration following injury (33, 34) . Our associations with SNPs in CCL2 and CCR2 are with skeletal muscle strength before our 12-wk training protocol. Skeletal muscle strength is not solely a property of the physical muscle but, also, a property of the nervous system (12) . Older individuals [82 Ϯ 1 (range 80 -86) yr, 74 Ϯ 4 kg body wt] who undertook a resistance-training program of the knee extensors (3 sets, 10 repetitions) at ϳ70% 1 RM, 3 days/wk for 12 wk, showed unaltered single muscle fiber contractile function and myosin heavy chain distribution with progressive resistance training (28) . The minor increases in whole muscle cross-sectional area coupled with the static nature of the myocellular profile indicate that the expression and development of strength are primarily neurological in nature (28) . CCL2 is known to activate the migration capacity of rat-derived neural stem cells (36) . In addition, expression of CCR2 was shown in neurosphere cultures as verified by RT-PCR and immunofluorescence microscopy (36) and is present in adult rat brain (2) . CCL2 might be engaged in a neuroprotective strategy involving the repression of NF-B activation that might lead to the inhibition of CCL2 expression (26) . The interplay between CCL2 and CCR2 may have important physiological and pathophysiological role(s) in the central nervous system, and this may be evident in the association of variants in both genes with pretraining muscle strength.
Some individuals who participated in the FAMUSS study did not respond to the exercise training (see Supplemental  Table S3 ). It has been suggested that prior training status may have an effect on response to muscle training (13) ; however, the individuals in our study were not supposed to have participated in resistance training in the previous 12 mo (31). Individuals who did not respond to training showed this lack of response in only one measure (1 RM, MVC, or muscle volume) and did not show correlations with any other measures of age or BMI (data not shown). We cannot infer the causes for lack of response to resistance training in this study. Further study may enable us to begin to unravel the biological mechanism of muscle response or lack of response to resistance training.
There are limitations to our study. The results of this study need to be verified in a replication population. Our study population contained only individuals of European descent (Caucasians); the results should be verified in different ethnic populations, which may have different allele frequencies. Finally, we limited our genetic variants in this study to those with a known or predicted function; however, the methods for prediction of function are computer-generated and require investigation using cellular methods.
We have found eight genetic variants in the CCL2 and CCR2 genes associated with measures of skeletal muscle strength and strength response to resistance training in men and women. These variants need to be explored further to determine their function within skeletal muscle cells. This study may be used to further expand the role of genetic variation in the development of an exercise blueprint that can be followed for maximum gains of skeletal muscle strength.
